Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8993 |
High Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8621 |
High Similarity |
NPD2532 |
Approved |
0.8621 |
High Similarity |
NPD2534 |
Approved |
0.8621 |
High Similarity |
NPD2533 |
Approved |
0.8298 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.8289 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8138 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8138 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8125 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.8099 |
Intermediate Similarity |
NPD1240 |
Approved |
0.8082 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.806 |
Intermediate Similarity |
NPD9545 |
Approved |
0.8 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7986 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7935 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7925 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.791 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7898 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7881 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7871 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7862 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7857 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7852 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7852 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7823 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7823 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7823 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7821 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7815 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7812 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7812 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7806 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7778 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7771 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7756 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7755 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7742 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7724 |
Intermediate Similarity |
NPD943 |
Approved |
0.7722 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7722 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7708 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7697 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7697 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7683 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7673 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7673 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7658 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7616 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.761 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7607 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7607 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7607 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7607 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7597 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7595 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7586 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7584 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7584 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7584 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7584 |
Intermediate Similarity |
NPD5408 |
Approved |
0.755 |
Intermediate Similarity |
NPD1243 |
Approved |
0.755 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7532 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.753 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7518 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7518 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7517 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7515 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7484 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7482 |
Intermediate Similarity |
NPD9268 |
Approved |
0.747 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7447 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7438 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7436 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7436 |
Intermediate Similarity |
NPD920 |
Approved |
0.7434 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7425 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7403 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7396 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7381 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7365 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7361 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7361 |
Intermediate Similarity |
NPD1164 |
Approved |
0.7361 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7351 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7351 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7347 |
Intermediate Similarity |
NPD411 |
Approved |
0.7342 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7337 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7337 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7324 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7315 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7313 |
Intermediate Similarity |
NPD74 |
Approved |
0.7313 |
Intermediate Similarity |
NPD9266 |
Approved |
0.7312 |
Intermediate Similarity |
NPD37 |
Approved |
0.7308 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7308 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7308 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7301 |
Intermediate Similarity |
NPD919 |
Approved |
0.7294 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7285 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7285 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7284 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7284 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7284 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7278 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7278 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7266 |
Intermediate Similarity |
NPD405 |
Clinical (unspecified phase) |
0.7257 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7256 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7239 |
Intermediate Similarity |
NPD9263 |
Approved |
0.7239 |
Intermediate Similarity |
NPD9264 |
Approved |
0.7239 |
Intermediate Similarity |
NPD9267 |
Approved |
0.7239 |
Intermediate Similarity |
NPD9265 |
Clinical (unspecified phase) |
0.7233 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.723 |
Intermediate Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.7226 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7225 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7212 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7211 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7208 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7195 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.719 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7183 |
Intermediate Similarity |
NPD4626 |
Approved |
0.716 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7113 |
Intermediate Similarity |
NPD5691 |
Approved |
0.7107 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7093 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7086 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7086 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7086 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7078 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7075 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.7066 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7063 |
Intermediate Similarity |
NPD1778 |
Approved |
0.7063 |
Intermediate Similarity |
NPD17 |
Approved |
0.7055 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7044 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7025 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7024 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7012 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7007 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.7 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7 |
Intermediate Similarity |
NPD9281 |
Approved |
0.7 |
Intermediate Similarity |
NPD3268 |
Approved |
0.6993 |
Remote Similarity |
NPD4196 |
Clinical (unspecified phase) |
0.6992 |
Remote Similarity |
NPD940 |
Approved |
0.6992 |
Remote Similarity |
NPD846 |
Approved |
0.6981 |
Remote Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.698 |
Remote Similarity |
NPD4908 |
Phase 1 |
0.6968 |
Remote Similarity |
NPD6002 |
Phase 3 |
0.6968 |
Remote Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.6968 |
Remote Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.6968 |
Remote Similarity |
NPD6004 |
Phase 3 |
0.6968 |
Remote Similarity |
NPD6005 |
Phase 3 |
0.6966 |
Remote Similarity |
NPD1610 |
Phase 2 |
0.6959 |
Remote Similarity |
NPD2798 |
Approved |
0.6959 |
Remote Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.6957 |
Remote Similarity |
NPD2181 |
Clinical (unspecified phase) |
0.6954 |
Remote Similarity |
NPD8312 |
Approved |
0.6954 |
Remote Similarity |
NPD520 |
Approved |
0.6954 |
Remote Similarity |
NPD6663 |
Approved |
0.6954 |
Remote Similarity |
NPD8313 |
Approved |
0.6952 |
Remote Similarity |
NPD8151 |
Discontinued |
0.6949 |
Remote Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.6943 |
Remote Similarity |
NPD7003 |
Approved |
0.694 |
Remote Similarity |
NPD9261 |
Approved |
0.6933 |
Remote Similarity |
NPD3027 |
Phase 3 |
0.6923 |
Remote Similarity |
NPD3926 |
Phase 2 |
0.6913 |
Remote Similarity |
NPD9494 |
Approved |
0.6913 |
Remote Similarity |
NPD5736 |
Approved |
0.6909 |
Remote Similarity |
NPD5353 |
Approved |
0.6908 |
Remote Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.6908 |
Remote Similarity |
NPD4060 |
Phase 1 |
0.6908 |
Remote Similarity |
NPD1613 |
Approved |
0.6905 |
Remote Similarity |
NPD1247 |
Approved |
0.6901 |
Remote Similarity |
NPD3751 |
Discontinued |
0.6899 |
Remote Similarity |
NPD2309 |
Approved |
0.6889 |
Remote Similarity |
NPD6535 |
Approved |
0.6889 |
Remote Similarity |
NPD6534 |
Approved |
0.6887 |
Remote Similarity |
NPD2313 |
Discontinued |
0.6887 |
Remote Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.6887 |
Remote Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.6884 |
Remote Similarity |
NPD4750 |
Phase 3 |
0.6879 |
Remote Similarity |
NPD1652 |
Phase 2 |
0.6871 |
Remote Similarity |
NPD4749 |
Approved |
0.6865 |
Remote Similarity |
NPD7435 |
Discontinued |
0.6864 |
Remote Similarity |
NPD3787 |
Discontinued |
0.6863 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6852 |
Remote Similarity |
NPD1653 |
Approved |
0.6849 |
Remote Similarity |
NPD1281 |
Approved |
0.6849 |
Remote Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.6839 |
Remote Similarity |
NPD4308 |
Phase 3 |
0.6839 |
Remote Similarity |
NPD3658 |
Clinical (unspecified phase) |
0.6835 |
Remote Similarity |
NPD8166 |
Discontinued |
0.6829
|
Remote Similarity |
NPD7615 |
Clinical (unspecified phase) |